Accueil   Agenda - News   Toutes les news Adocia announces two new multi-hormonal combination projects

Adocia announces two new multi-hormonal combination projects

Adocia announces two new multi-hormonal combination projects for the treatment of type 1 diabetes

 

  • BioChaperone® enables combinations of insulin lispro with pramlintide and insulin lispro with exenatide, three hormones approved for the treatment of diabetes.
  • Medical benefit of such combinations already established in type 1 diabetes clinical trials with separate injections.
  • New projects aim to offer more efficient therapy to people living with type 1 diabetes without increasing number of injections.
  • First clinical study expected to start in Q4 2017.

 

Voir le communiqué de presse

En poursuivant votre navigation sur ce site, vous acceptez l'utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d'intérêt. En savoir plus... Fermer